Latest News

Analysts flagging oversold conditions across SaaS have pushed some investors back toward established names, and Bentley Systems (BSY) is feeling that shift as attention turns to its infrastructure focused software franchise. See our latest analysis for Bentley Systems. At a share price of US$34.10, Bentley Systems has seen a 6.5% 7 day share price return after a 30 day share price decline of 13.6% and a 90 day share price decline of 21%. Its 1 year total shareholder return sits at a 26.6%...

Why Norwegian Cruise Line Holdings (NCLH) is Back on Investor Radars Norwegian Cruise Line Holdings (NCLH) has caught investor attention after a recent stretch of mixed share performance, including a past 3 months total return of 27.12% and a 1 year total return decline of 11.70%. See our latest analysis for Norwegian Cruise Line Holdings. At a share price of $23.25, Norwegian Cruise Line Holdings has seen momentum pick up recently, with a 7 day share price return of 7.14% and a 90 day share...

If you are wondering whether Brookfield Asset Management is fairly priced or presenting an opportunity, a useful starting point is to look closely at what the current share price implies about its long term value. The stock last closed at C$70.75, with returns of 6.2% over the past 7 days, a 2.9% decline over 30 days, a 3.6% decline year to date, and a 10.6% decline over 1 year, while the 3 year return sits at 64.9%. Recent news coverage around Brookfield Asset Management has focused on its...

Why Lincoln National is back on investors' radar Lincoln National (LNC) is drawing fresh attention as the market looks ahead to its upcoming Q4 earnings report, with expectations for revenue growth and a mixed track record against past estimates. See our latest analysis for Lincoln National. The upcoming Q4 earnings report has arrived after a choppy run for the stock, with a 1 day share price return of 5.64% to US$40.67 contrasting with a weaker year to date share price return of 9.64%. The 1...

What Evolution’s record half year means for shareholders Evolution Mining (ASX:EVN) has reported record half year numbers, with revenue of A$2,794.35 million and net profit of A$766.57 million, alongside a fully franked interim dividend of A$0.20 per share. For you as an investor, the combination of higher earnings per share, lower net debt over the past two years and a materially larger dividend sits at the centre of the current investment story. See our latest analysis for Evolution...

Kyndryl Holdings recently faced an internal accounting review tied to SEC document requests, leadership changes including the abrupt exit of its CFO and General Counsel, delayed filing of its December 2025 10-Q, and multiple shareholder lawsuits alleging weaknesses in financial reporting controls. At the same time, the company has continued to roll out policy-governed agentic AI capabilities and maintain capital return activities such as share buybacks, underscoring the contrast between its...

Koninklijke Philips (ENXTAM:PHIA) is back in the spotlight after reporting a return to profitability in 2025, setting new 2026 sales and margin targets, and unveiling fresh AI focused and pediatric imaging products. See our latest analysis for Koninklijke Philips. The earnings rebound, new 2026 targets and fresh AI and pediatric imaging launches have gone hand in hand with a 7 day share price return of 8.42% and year to date share price return of 15.27%. The 3 year total shareholder return of...

DraftKings (NasdaqGS:DKNG) announced an expansion of its federally regulated prediction markets through a new partnership with Crypto.com. The company is growing its Predictions platform to include event contracts tied to sports, culture, and politics. New offerings include player specific event contracts for NFL and NBA games, along with contracts linked to entertainment and broader cultural events. For you as an investor, this move signals DraftKings pushing beyond its traditional core of...

If you are wondering whether LifeStance Health Group is attractively priced or still carrying a premium, you are not alone. This article is built to unpack what the current share price might be implying. The stock last closed at US$6.92, with a recent 7 day return of 5.8%, a 30 day return of 4.6% decline, and year to date and 1 year returns of 0.6% decline and 13.4% decline respectively, set against a 3 year return of 23.1%. Recent news coverage around LifeStance Health Group has focused on...

Zillow Group (ZG) has investors’ attention after reporting its first full year of profit since 2012, paired with double digit revenue growth in key segments. However, higher legal costs and cautious guidance are keeping sentiment restrained. See our latest analysis for Zillow Group. Despite the stronger operating results, sentiment has turned sharply, with a 1 day share price return of negative 3.10% and a 30 day share price return of negative 35.55% following cautious guidance, legal cost...

Allison Transmission Holdings (NYSE:ALSN) has completed its acquisition of Dana Incorporated’s Off-Highway Drive & Motion Systems business. The deal adds operations across 29 countries, significantly widening Allison’s international footprint. The transaction reshapes Allison’s presence in off highway drivetrain and motion solutions markets. Allison Transmission, known for its fully automatic transmissions for commercial and defense vehicles, is now expanding further into off highway...

Neuren Pharmaceuticals (ASX:NEU) has announced a new share buy-back program, authorising repurchases of up to 6,350,631 shares, or 5% of its issued capital, through to March 2027. See our latest analysis for Neuren Pharmaceuticals. The buy-back comes after a sharp 30 day share price return of around a 30% decline and a 90 day share price return of about a 29% decline, even though the 1 year and multi year total shareholder returns remain positive and very strong. This suggests recent selling...

Madrigal Pharmaceuticals (NasdaqGS:MDGL) granted inducement equity awards to 21 newly hired non executive employees. The awards follow regulatory approval of the company’s lead MASH treatment, Rezdiffra, which is currently described as the first and only FDA and European Commission approved therapy for MASH with moderate to advanced fibrosis. The grants are intended as material inducements to join Madrigal, aligning new hires with shareholder interests after recent regulatory...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Commercial Services industry in Hong Kong, you...

The Nomura Research Institute, Ltd. ( TSE:4307 ) share price has fared very poorly over the last month, falling by a...

Precision Wires India's (NSE:PRECWIRE) stock is up by a considerable 23% over the past month. Given the company's...

With a price-to-earnings (or "P/E") ratio of 29.7x Alkem Laboratories Limited ( NSE:ALKEM ) may be sending bearish...

Despite an already strong run, Sudatel Telecom Group Limited ( ADX:SUDATEL ) shares have been powering on, with a gain...

The Australian market has been experiencing a turbulent period, with concerns over artificial intelligence and tech sector volatility affecting investor sentiment. Despite these challenges, investors continue to seek opportunities in various sectors, including penny stocks. While the term 'penny stock' might feel outdated, it remains relevant as these smaller or newer companies can offer affordability and growth potential when backed by solid financials. Let's explore three ASX penny stocks...

Celebrations may be in order for ADNOC Gas PLC ( ADX:ADNOCGAS ) shareholders, with the analysts delivering a...

It's been a good week for Emirates Central Cooling Systems Corporation ( DFM:EMPOWER ) shareholders, because the...

NMDC Group PJSC's ( ADX:NMDC ) robust earnings report didn't manage to move the market for its stock. We did some...

While Radico Khaitan Limited ( NSE:RADICO ) shareholders are probably generally happy, the stock hasn't had...

It's been a good week for Emirates Integrated Telecommunications Company PJSC ( DFM:DU ) shareholders, because the...